Turkiye Klinikleri Cardiovascular Sciences

.: REVIEW
Tpeak-Tend Interval and its Derivatives as Indices of Repolarization Dispersion and Arrhythmic Risk: Traditional Review
Repolarizasyon Dağılımı ve Aritmik Risk Göstergeleri Olarak Tpeak-Tend Aralığı ve Türevleri: Geleneksel Derleme
Natalia ARTEYEVAa
aDepartment of Cardiac Physiology, Institute of Physiology, Komi Science Center, Ural Branch, Russian Academy of Sciences, Syktyvkar, Russia
Turkiye Klinikleri J Cardiovasc Sci. 2024;36(1):27-34
doi: 10.5336/cardiosci.2023-100358
Article Language: EN
Full Text
ABSTRACT
Development of life-threatening ventricular arrhythmias is often associated with an increase in the dispersion of ventricular repolarization (DOR), which can be detected by electrocardiographic (ECG) methods. For several decades, there was an active search for ECG markers reflecting the magnitude of DOR and the associated arrhythmic risk. The interval from the peak to the end of the T-wave (Tpe) was found to be the most accurate measure of DOR and a reliable marker of arrhythmic risk in various cardiac disorders. In addition to Tpe interval itself, its derivatives-Tpe dispersion and Tpe/QT ratiowere proposed as arrhythmic risk markers. In this review, several aspects regarding Tpe and its derivatives are discussed: (1) physiological rationale for relationship to DOR and arrhythmic risk, (2) clinical significance for predicting ventricular arrhythmias, and (3) clinical limitations. Based on the experimental, clinical and simulation studies, the review demonstrates that Tpe, dTpe and Tpe/QT ratio are informative concerning both the global and the local DOR. They are significant predictors of arrhythmias associated with increased DOR, and the overall mortality. Besides, Tpe magnitude showed itself as a simple, non-invasive, inexpensive and quick indirect assessment of hemodynamic and volumetric ventricular parameters, the extent and severity of coronary artery stenosis, therapy response and the expected hospital stay. However, the lack of consensus in measurements led to large variations of cut-off values reported by different researchers. The inclusion of Tpe in routine ECG analysis requires further research based on the more unified measurements, including machine learning and artificial intelligence tools.

Keywords: Repolarization dispersion; arrhythmic risk; Tpeak-Tend interval; Tpeak-Tend dispersion; Tpeak-Tend/QT ratio
ÖZET
Hayatı tehdit eden ventriküler aritmilerin gelişimi, genellikle elektrokardiyografik (EKG) yöntemlerle tespit edilebilen ventriküler repolarizasyon dispersiyonundaki [dispersion of ventricular repolarization (DOR)] bir artışla ilişkilidir. Onlarca yıl boyunca, DOR'un büyüklüğünü ve ilgili aritmik riski yansıtan EKG belirteçleri için aktif bir araştırma yapılmıştır. T-dalga zirvesinden sonuna kadar olan aralık (Tpe), DOR'un en doğru ölçüsü ve çeşitli kardiyak bozukluklarda güvenilir bir aritmik risk belirteci olarak bulunmuştur. Tpe aralığının kendisine ek olarak, türevleri - Tpe dispersiyonu ve Tpe/QT oranıaritmik risk belirteçleri olarak önerilmiştir. Bu derlemede, Tpe ve türevlerine ilişkin çeşitli yönler tartışılmaktadır: (1) DOR ve aritmik risk ile ilişki için fizyolojik gerekçe, (2) ventriküler aritmilerin öngörülmesinde klinik önem ve (3) klinik kısıtlamalar. Deneysel, klinik ve simülasyon çalışmalarına dayanarak, bu derleme, Tpe, dTpe ve Tpe/QT oranının hem küresel hem de lokal DOR hakkında bilgilendirici olduğunu göstermektedir. Bunlar, artmış DOR ile ilişkili aritmilerin ve genel mortalitenin önemli öngörücüleridir. Ayrıca Tpe büyüklüğü hemodinamik ve volümetrik ventriküler parametrelerin, koroner arter stenozunun kapsamı ve şiddeti, tedaviye yanıtın ve beklenen hastanede kalış süresinin basit, invaziv olmayan, ucuz ve hızlı bir dolaylı değerlendirmesi olarak kendini göstermiştir. Ancak ölçümlerde fikir birliği olmaması, farklı araştırmacılar tarafından bildirilen eşik değerlerinde büyük farklılıklara yol açmıştır. Tpe'nin rutin EKG analizine dâhil edilmesi, daha birleşik ölçümlere dayanan, makine öğrenimi ve yapay zekâ araçlarını içeren daha fazla araştırma gerektirmektedir.

Anahtar Kelimeler: Repolarizasyon dispersiyonu; aritmik risk; Tpeak-Tend aralığı; Tpeak-Tend dispersiyonu; Tpeak-Tend/QT oranı
REFERENCES:
  1. Osadchii OE. Role of abnormal repolarization in the mechanism of cardiac arrhythmia. Acta Physiol (Oxf). 2017;220 Suppl 712:1-71. [Crossref]  [PubMed] 
  2. Antzelevitch C, Di Diego JM. Tpeak-Tend interval as a marker of arrhythmic risk. Heart Rhythm. 2019;16(6):954-5. [Crossref]  [PubMed]  [PMC] 
  3. Castro Hevia J, Antzelevitch C, Tornés Bárzaga F, Dorantes Sánchez M, Dorticós Balea F, Zayas Molina R, et al. Tpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia/ventricular fibrillation in patients with the Brugada syndrome. J Am Coll Cardiol. 2006;47(9):1828-34. [Crossref]  [PubMed]  [PMC] 
  4. Gupta P, Patel C, Patel H, Narayanaswamy S, Malhotra B, Green JT, et al. T(p-e)/QT ratio as an index of arrhythmogenesis. J Electrocardiol. 2008;41(6):567-74. [Crossref]  [PubMed] 
  5. Tse G, Yan BP. Traditional and novel electrocardiographic conduction and repolarization markers of sudden cardiac death. Europace. 2017;19(5):712-21. [Crossref]  [PubMed] 
  6. Yan GX, Antzelevitch C. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome. Circulation. 1998;98(18):1928-36. [Crossref]  [PubMed] 
  7. Xia Y, Liang Y, Kongstad O, Holm M, Olsson B, Yuan S. Tpeak-Tend interval as an index of global dispersion of ventricular repolarization: evaluations using monophasic action potential mapping of the epi- and endocardium in swine. J Interv Card Electrophysiol. 2005;14(2):79-87. [Crossref]  [PubMed] 
  8. Opthof T, Coronel R, Wilms-Schopman FJ, Plotnikov AN, Shlapakova IN, Danilo P Jr, et al. Dispersion of repolarization in canine ventricle and the electrocardiographic T wave: Tp-e interval does not reflect transmural dispersion. Heart Rhythm. 2007;4(3):341-8. [Crossref]  [PubMed] 
  9. Arteyeva NV, Goshka SL, Sedova KA, Bernikova OG, Azarov JE. What does the T(peak)-T(end) interval reflect? An experimental and model study. J Electrocardiol. 2013;46(4):296.e1-8. [Crossref]  [PubMed] 
  10. Arteyeva NV, Azarov JE. Scenarios for Increasing, Decreasing and Stability of Tpe/QT Ratio (Simulation Study). International Journal of Biomedicine. 2022;12(4):535-8. [Crossref] 
  11. Korantzopoulos P, Letsas KP, Christogiannis Z, Kalantzi K, Massis I, Goudevenos JA. Gender effects on novel indexes of heterogeneity of repolarization in patients with stable coronary artery disease. Hellenic J Cardiol. 2011;52(4):311-5. [PubMed] 
  12. Sucu M, Ucaman B, Ozer O, Altas Y, Polat E. Novel Ventricular Repolarization Indices in Patients with Coronary Slow Flow. J Atr Fibrillation. 2016;9(3):1446. [Crossref]  [PubMed]  [PMC] 
  13. Tse G, Bazoukis G, Roever L, Liu T, Wu WKK, Wong MCS, et al. T-wave indices and atherosclerosis. Curr Atheroscler Rep. 2018;20(11):55. [Crossref]  [PubMed] 
  14. Panikkath R, Reinier K, Uy-Evanado A, Teodorescu C, Hattenhauer J, Mariani R, et al. Prolonged Tpeak-to-tend interval on the resting ECG is associated with increased risk of sudden cardiac death. Circ Arrhythm Electrophysiol. 2011;4(4):441-7. [Crossref]  [PubMed]  [PMC] 
  15. Asil S, Geneş M, Yaşar S, Fırtına S, Görmel S, Yıldırım E, et al. Atrial and ventricular arrhythmia predictors with electrocardiographic parameters in myocardial infarction with non-obstructive coronary artery disease (MINOCA). Cardiovasc J Afr. 2023;34(4):206-11. [Crossref]  [PubMed] 
  16. Lin XM, Yang XL, Liu HL, Lai YQ. [Relationship between Tpeak-Tend interval and coronary artery stenosis and effects of percutaneous transluminal coronary angioplasty on Tpeak-Tend]. Nan Fang Yi Ke Da Xue Xue Bao. 2010;30(8):1877-9. Chinese. [PubMed] 
  17. Ciobanu A, Tse G, Liu T, Deaconu MV, Gheorghe GS, Ilieşiu AM, et al. Electrocardiographic measures of repolarization dispersion and their relationships with echocardiographic indices of ventricular remodeling and premature ventricular beats in hypertension. J Geriatr Cardiol. 2017;14(12):717-24. [PubMed]  [PMC] 
  18. Mozos I. The link between ventricular repolarization variables and arterial function. J Electrocardiol. 2015;48(2):145-9. [Crossref]  [PubMed] 
  19. Tse G, Gong M, Wong WT, Georgopoulos S, Letsas KP, Vassiliou VS, et al. The Tpeak - Tend interval as an electrocardiographic risk marker of arrhythmic and mortality outcomes: A systematic review and meta-analysis. Heart Rhythm. 2017;14(8):1131-7. [Crossref]  [PubMed] 
  20. Tse G, Wong CW, Gong MQ, Meng L, Letsas KP, Li GP, et al; International Health Informatics Study (IHIS) Network. Meta-analysis of T-wave indices for risk stratification in myocardial infarction. J Geriatr Cardiol. 2017;14(12):776-9. [PubMed]  [PMC] 
  21. Azarov JE, Demidova MM, Koul S, van der Pals J, Erlinge D, Platonov PG. Progressive increase of the Tpeak-Tend interval is associated with ischaemia-induced ventricular fibrillation in a porcine myocardial infarction model. Europace. 2018;20(5):880-6. [Crossref]  [PubMed] 
  22. Özbek SC, Sökmen E. Usefulness of Tp-Te interval and Tp-Te/QT ratio in the prediction of ventricular arrhythmias and mortality in acute STEMI patients undergoing fibrinolytic therapy. J Electrocardiol. 2019;56:100-5. [Crossref]  [PubMed] 
  23. Cetin M, Zencir C, Cakici M, Yildiz E, Tasolar H, Balli M, et al. Effect of a successful percutaneous coronary intervention for chronic total occlusion on parameters of ventricular repolarization. Coron Artery Dis. 2014;25(8):705-12. [Crossref]  [PubMed] 
  24. Duyuler PT, Duyuler S, Demir M. Impact of myocardial blush grade on Tpe interval and Tpe/QT ratio after successful primary percutaneous coronary intervention in patients with ST elevation myocardial infarction. Eur Rev Med Pharmacol Sci. 2017;21(1):143-9. [PubMed] 
  25. Akcay M, Coksevim M, Yenercag M. Effect of ranolazine on Tp-e interval, Tp-e/QTc, and P-wave dispersion in patients with stable coronary artery disease. J Arrhythm. 2021;37(4):1015-22. [Crossref]  [PubMed]  [PMC] 
  26. Piccirillo G, Moscucci F, Carnovale M, Bertani G, Lospinuso I, Di Diego I, et al. QT and Tpeak-Tend interval variability: Predictive electrical markers of hospital stay length and mortality in acute decompensated heart failure. Preliminary data. Clin Cardiol. 2022;45(12):1192-8. [Crossref]  [PubMed]  [PMC] 
  27. Piccirillo G, Moscucci F, Carnovale M, Corrao A, Di Diego I, Lospinuso I, et al. Glucose dysregulation and repolarization variability markers are short-term mortality predictors in decompensated heart failure. Cardiovasc Endocrinol Metab. 2022;11(3):e0264. [Crossref]  [PubMed]  [PMC] 
  28. Xue C, Hua W, Cai C, Ding LG, Niu HX, Fan XH, et al. Predictive value of Tpeak-Tend interval for ventricular arrhythmia and mortality in heart failure patients with an implantable cardioverter-defibrillator: A cohort study. Medicine (Baltimore). 2019;98(49):e18080. [Crossref]  [PubMed]  [PMC] 
  29. Usalp S, Gündüz R. Use of T-wave duration and Tpeak-Tend interval as new prognostic markers for patients treated with cardiac resynchronization therapy. Kardiol Pol. 2021;79(6):676-83. [Crossref]  [PubMed] 
  30. Tse G, Gong M, Meng L, Wong CW, Georgopoulos S, Bazoukis G, et al. Meta-analysis of Tpeak-Tend and Tpeak-Tend/QT ratio for risk stratification in congenital long QT syndrome. J Electrocardiol. 2018;51(3):396-401. [Crossref]  [PubMed] 
  31. Castro-Torres Y, Carmona-Puerta R, Katholi RE. Ventricular repolarization markers for predicting malignant arrhythmias in clinical practice. World J Clin Cases. 2015;3(8):705-20. [Crossref]  [PubMed]  [PMC] 
  32. Tse G, Gong M, Li CKH, Leung KSK, Georgopoulos S, Bazoukis G, et al; International Health Informatics Study (IHIS) Network. Tpeak-Tend, Tpeak-Tend/QT ratio and Tpeak-Tend dispersion for risk stratification in Brugada Syndrome: A systematic review and meta-analysis. J Arrhythm. 2018;34(6):587-97. [PubMed]  [PMC] 
  33. Zumhagen S, Zeidler EM, Stallmeyer B, Ernsting M, Eckardt L, Schulze-Bahr E. Tpeak-Tend interval and Tpeak-Tend/QT ratio in patients with Brugada syndrome. Europace. 2016;18(12):1866-72. [PubMed] 
  34. Cekirdekci EI, Bugan B. Can abnormal dispersion of ventricular repolarization be a predictor of mortality in arrhythmogenic right ventricular cardiomyopathy: The importance of Tp-e interval. Ann Noninvasive Electrocardiol. 2019;24(3):e12619. [Crossref]  [PubMed]  [PMC] 
  35. Golcuk E, Yalin K, Kaya Bilge A, Elitok A, Aksu T, Akgun T, et al. Usefulness of T(peak) -T(end) interval to distinguish arrhythmogenic right ventricular cardiomyopathy from idiopathic right ventricular outflow tract tachycardia. Pacing Clin Electrophysiol. 2014;37(12):1665-70. [Crossref]  [PubMed] 
  36. Braschi A, Frasheri A, Lombardo RM, Abrignani MG, Lo Presti R, Vinci D, et al. Association between Tpeak-Tend/QT and major adverse cardiovascular events in patients with Takotsubo syndrome. Acta Cardiol. 2021;76(7):732-8. [Crossref]  [PubMed] 
  37. Li Y, Lu W, Hu Q, Cheng C, Lin J, Zhou Y, et al. Changes of repolarization parameters after left bundle branch area pacing and the association with echocardiographic response in heart failure patients. Front Physiol. 2022;13:912126. [Crossref]  [PubMed]  [PMC] 
  38. Ece İ, Koçoğlu M, Kavurt AV, Bağrul D, Gül AEK, Koca S, et al. Assessment of Cardiac Arrhythmic Risk in Children With Covid-19 Infection. Pediatr Cardiol. 2021;42(2):264-8. [Crossref]  [PubMed]  [PMC] 
  39. Açar B, Yüksel M, Yayla Ç, Kırbaş Ö, Ünal S, Ertem AG, et al. Parameters of ventricular repolarization in patients with autoimmune hepatitis. Turk Kardiyol Dern Ars. 2017;45(4):333-8. [PubMed] 
  40. Tokatli A, Kiliçaslan F, Alis M, Yiginer O, Uzun M. Prolonged Tp-e Interval, Tp-e/QT Ratio and Tp-e/QTc Ratio in Patients with Type 2 Diabetes Mellitus. Endocrinol Metab (Seoul). 2016;31(1):105-12. [Crossref]  [PubMed]  [PMC] 
  41. Altun Y , Yasar E . Effects of valproate, carbamazepine and levetiracetam on Tp-e interval, Tp-e/QT and Tp-e/QTc ratio. Ideggyogy Sz. 2020;73(3-4):121-7. English. [Crossref]  [PubMed] 
  42. Akcay M, Yıldırım U. Effect of dialysis and transplantation on myocardial repolarization parameters and P-wave dispersion in chronic kidney disease. J Arrhythm. 2021;37(2):348-55. [Crossref]  [PubMed]  [PMC] 
  43. Masoud S, Lim PB, Kitas GD, Panoulas V. Sudden cardiac death in patients with rheumatoid arthritis. World J Cardiol. 2017;9(7):562-73. [Crossref]  [PubMed]  [PMC] 
  44. Balcioglu YH, Gokcay H, Kirlioglu Balcioglu SS, Solmaz M. Increased dispersion of ventricular repolarization as an arrhythmic risk marker in drug-free patients with major depressive disorder: a preliminary comparative study. J Psychiatr Pract. 2023;29(4):282-90. [Crossref]  [PubMed] 
  45. Okutucu S, Karakulak UN, Aksoy H, Sabanoglu C, Hekimsoy V, Sahiner L, et al. Prolonged Tp-e interval and Tp-e/QT correlates well with modified Rodnan skin severity score in patients with systemic sclerosis. Cardiol J. 2016;23(3):242-9. [Crossref]  [PubMed] 
  46. Unal Evren E, Cekirdekci EI, Evren H, Suer K, Sarigul Yildirim F, Asan A, et al. Abnormal Dispersion of Ventricular Repolarization as a Risk Factor in Patients with Human Immunodeficiency Virus: Tp-e Interval, Tp-e/QTc Ratio. Med Princ Pract. 2020;29(6):544-50. [Crossref]  [PubMed]  [PMC] 
  47. Braun CC, Zink MD, Gozdowsky S, Hoffmann JM, Hochhausen N, Röhl AB, et al. A Longer Tpeak-Tend Interval Is Associated with a Higher Risk of Death: A Meta-Analysis. J Clin Med. 2023;12(3):992. [Crossref]  [PubMed]  [PMC] 
  48. Bachmann TN, Skov MW, Rasmussen PV, Graff C, Pietersen A, Lind B, et al. Electrocardiographic Tpeak-Tend interval and risk of cardiovascular morbidity and mortality: Results from the Copenhagen ECG study. Heart Rhythm. 2016;13(4):915-24. [Crossref]  [PubMed] 
  49. Lei M, Salvage SC, Jackson AP, Huang CL. Cardiac arrhythmogenesis: roles of ion channels and their functional modification. Front Physiol. 2024;15:1342761. [Crossref]  [PubMed]  [PMC] 
  50. Lu HR, Yan GX, Gallacher DJ. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs). J Pharmacol Toxicol Methods. 2013;68(2):250-9. [Crossref]  [PubMed] 
  51. Reinier K, Narayanan K, Uy-Evanado A, Teodorescu C, Chugh H, Mack WJ, et al. Electrocardiographic Markers and the Left Ventricular Ejection Fraction have Cumulative Effects on Risk of Sudden Cardiac Death. JACC Clin Electrophysiol. 2015;1(6):542-50. [Crossref]  [PubMed]  [PMC] 
  52. Myerburg RJ, Junttila MJ. Sudden cardiac death caused by coronary heart disease. Circulation. 2012;125(8):1043-52. [Crossref]  [PubMed] 
  53. Braschi A, Abrignani MG, Francavilla VC, Abrignani V, Francavilla G. Age- and sex-based reference ranges for non-invasive ventricular repolarisation parameters. Int J Clin Pract. 2017;71(5). [Crossref]  [PubMed] 
  54. Hnatkova K, Toman O, ?i?áková M, Smetana P, Huster KM, Barthel P, et al. Sex and race differences in J-Tend, J-Tpeak, and Tpeak-Tend intervals. Sci Rep. 2019;9(1):19880. [Crossref]  [PubMed]  [PMC] 
  55. Chua KC, Rusinaru C, Reinier K, Uy-Evanado A, Chugh H, Gunson K, et al. Tpeak-to-Tend interval corrected for heart rate: A more precise measure of increased sudden death risk? Heart Rhythm. 2016;13(11):2181-5. [Crossref]  [PubMed]  [PMC] 
  56. El-Hamad F, Javorka M, Czippelova B, Krohova J, Turianikova Z, Porta A, et al. Repolarization variability independent of heart rate during sympathetic activation elicited by head-up tilt. Med Biol Eng Comput. 2019;57(8):1753-62. [Crossref]  [PubMed] 
  57. Haarmark C, Graff C, Andersen MP, Hardahl T, Struijk JJ, Toft E, et al. Reference values of electrocardiogram repolarization variables in a healthy population. J Electrocardiol. 2010;43(1):31-9. [Crossref]  [PubMed] 
  58. Maury P, Sacher F, Gourraud JB, Pasquié JL, Raczka F, Bongard V, et al. Increased Tpeak-Tend interval is highly and independently related to arrhythmic events in Brugada syndrome. Heart Rhythm. 2015;12(12):2469-76. [Crossref]  [PubMed] 
  59. Mugnai G, Hunuk B, Hernandez-Ojeda J, Stroker E, Velagic V, Ciconte G, et al. Role of Electrocardiographic Tpeak-Tend for the Prediction of Ventricular Arrhythmic Events in the Brugada Syndrome. Am J Cardiol. 2017;120(8):1332-7. [Crossref]  [PubMed] 
  60. Haarmark C, Hansen PR, Vedel-Larsen E, Pedersen SH, Graff C, Andersen MP, et al. The prognostic value of the Tpeak-Tend interval in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. J Electrocardiol. 2009;42(6):555-60. [Crossref]  [PubMed] 

.: Up To Date

.: Process List

Login



Contact


Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com